middle.news
Echo IQ Surpasses Expectations in Mayo Clinic Heart Failure Study
8:35am on Monday 24th of November, 2025 AEDT
•
Healthcare
Read Story
Echo IQ Surpasses Expectations in Mayo Clinic Heart Failure Study
8:35am on Monday 24th of November, 2025 AEDT
Key Points
EchoSolv HF validation completed with 99.5% sensitivity and 91.0% specificity
Study conducted on 17,000 echocardiograms via Mayo Clinic Platform
Final clinical step before FDA 510(k) submission expected imminently
Potential to address under-diagnosis in US heart failure market valued at $60 billion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Echoiq (ASX:EIQ)
OPEN ARTICLE